C4X Discovery has been developing potential oral IL-17 inhibitor drug, which could be used to treat autoimmune diseases including psoriasis, psoriatic arthritis and ankylosing spondylitis.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback